EconomicChina·2 Nov 2026
Japanese firm Rohto Pharmaceutical to conduct clinical trials in Hong Kong
AI-summarized · Neutrality-checked
Japanese firm Rohto Pharmaceutical became the first company from Japan to partner with the Hong Kong government under the Office for Attracting Strategic Enterprises (OASES) initiative. The company was recruited as part of a group of 18 firms to conduct clinical trials in the city. Chairman Kunio Yamada stated that the firm's decision was driven by Hong…
Loading full story…
Sources and context
SCMP
NewspaperCompany ownedHong KongStandards published
Source-level context, not a score for this article. Methodology and evidence · Report outdated information
Know where. Know why.